Cite
HARVARD Citation
Cancelas, J. et al. (2017). Red blood cell concentrates treated with the amustaline (S‐303) pathogen reduction system and stored for 35 days retain post‐transfusion viability: results of a two‐centre study. Vox sanguinis. 112 (3), pp. 210-218. [Online].